CompanyScope

Dexcom, Inc. (DXCM)

Ticker DXCM · SEC CIK 1093557 · Latest fiscal year ended Dec 31, 2025

Dexcom, Inc. reported revenue of $4.66B for the fiscal year ended Dec 31, 2025, up 15.6% from $4.03B the year before. Net income was $836.30M, a net margin of 17.9% (prior year: $576.20M). At the end of that fiscal year the company reported total assets of $6.34B and shareholders' equity of $2.75B.

Revenue
$4.66B
+15.6% vs prior year
Net income
$836.30M
Net margin 17.9%
Diluted EPS
$2.09
USD per share
Total assets
$6.34B
At Dec 31, 2025
Equity
$2.75B
At Dec 31, 2025
Shares outstanding
373M
As of Oct 22, 2026
$0$2B$4B$6BDec 2016: $573.30MDec 2017: $718.50MDec 2018: $1.03BDec 2019: $1.48BDec 2020: $1.93BDec 2021: $2.45BDec 2022: $2.91BDec 2023: $3.62BDec 2024: $4.03BDec 2025: $4.66BDec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Dexcom, Inc. annual revenue, USD. Hover a bar for the exact figure.

Explore Dexcom, Inc.'s filings

Latest SEC filings

Source: SEC EDGAR XBRL company facts for CIK 1093557 (raw data). Most recent filing in this dataset: 10-Q filed Oct 29, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.